A recent announcement from Hims and Hers Health Inc indicates the company has expanded its medication offerings to include GLP-1 receptor agonists manufactured by Eli Lilly, adding to the existing semaglutide products previously available through their telehealth platform. The company’s leadership drew a parallel to Netflix’s early strategic positioning, suggesting this represents a significant market expansion opportunity as GLP-1 medications continue to gain clinical prominence for both glycemic control and cardiovascular benefit in appropriate patient populations. This development reflects the broader pharmaceutical market trend toward increased accessibility of GLP-1 therapies through direct-to-consumer telemedicine channels.
The expansion occurs against a backdrop of ongoing policy discussions regarding reimbursement coverage. A reported delay in a Medicare pilot program that would have covered GLP-1 medication costs underscores current access challenges in this therapeutic category. Existing access through platforms such as Hims and Hers requires active medical supervision and appropriate patient selection, including comprehensive assessment for contraindications and monitoring of gastrointestinal tolerability and metabolic effects. The addition of Lilly’s GLP-1 portfolio to an established telehealth infrastructure may increase patient options for obtaining these medications, though prescribers should maintain standard clinical evaluation protocols regarding patient suitability, dosing titration, and ongoing monitoring regardless of distribution channel.
The practical implications for prescribers include awareness of expanded medication availability through non-traditional care settings and the need to remain vigilant regarding appropriate patient selection, drug interactions, and medication adherence monitoring when patients access GLP-1 therapies through telehealth platforms. As this therapeutic category continues to evolve in both clinical application and market access, practitioners should continue relying on established clinical guidelines and contraindication assessment to guide prescribing decisions.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is a GLP-1 medication and how does it work?
- What is the difference between Ozempic and Wegovy?
- Is Lilly’s GLP-1 the same as Ozempic or Wegovy?
- Will Medicare cover the cost of GLP-1 medications?
- What companies now offer GLP-1 medications?
- Can I get GLP-1 medications through online platforms like Hims?
- Who is eligible to use GLP-1 medications?
- What are common side effects of GLP-1 medications?
- Do I need to take GLP-1 medications forever?
- How much do GLP-1 medications cost without insurance?
FAQ
What is a GLP-1 medication and how does it work?
GLP-1 medications are drugs that mimic a natural hormone in your body called glucagon-like peptide-1, which helps regulate blood sugar and appetite. These medications work by slowing digestion, increasing feelings of fullness, and helping your body use insulin more effectively.
What is the difference between Ozempic and Wegovy?
Ozempic is a GLP-1 medication approved for type 2 diabetes management, while Wegovy is the same active ingredient approved specifically for weight loss in people without diabetes. Both contain semaglutide but are marketed for different purposes.
Is Lilly’s GLP-1 the same as Ozempic or Wegovy?
No, Lilly’s GLP-1 medications use a different active ingredient called tirzepatide, which is marketed as Zepbound for weight loss and Mounjaro for diabetes. While both are GLP-1 class medications, they have different chemical structures and may work differently in your body.
Will Medicare cover the cost of GLP-1 medications?
Medicare coverage for GLP-1 medications is currently limited, though discussions are ongoing with the Trump administration about expanding access. Your out-of-pocket costs will depend on your specific insurance plan and whether your doctor prescribes it for an approved indication like diabetes.
What companies now offer GLP-1 medications?
Major pharmaceutical companies including Novo Nordisk (Ozempic and Wegovy), Eli Lilly (Mounjaro and Zepbound), and online telehealth platforms like Hims and Hers now offer GLP-1 medications. Availability varies by company and may depend on your location and insurance coverage.
Can I get GLP-1 medications through online platforms like Hims?
Yes, Hims and Hers and other telehealth companies now offer GLP-1 medications after completing a virtual consultation with a healthcare provider. You will need to be evaluated by a doctor to ensure the medication is appropriate for your medical history.
Who is eligible to use GLP-1 medications?
GLP-1 medications are prescribed for people with type 2 diabetes to improve blood sugar control or for people with obesity or overweight who meet certain criteria. Your doctor will evaluate your medical history, current medications, and health conditions to determine if a GLP-1 is right for you.
What are common side effects of GLP-1 medications?
Common side effects include nausea, vomiting, diarrhea, and constipation, particularly when starting the medication or increasing the dose. Most side effects improve over time as your body adjusts, but you should report persistent or severe symptoms to your doctor.
Do I need to take GLP-1 medications forever?
The duration depends on why you are taking the medication and how your body responds. Your doctor will monitor your progress and discuss whether you can reduce the dose or stop the medication if you achieve your health goals.
How much do GLP-1 medications cost without insurance?
Out-of-pocket costs vary widely depending on the medication and where you purchase it, ranging from under 100 dollars to over 900 dollars per month for name-brand options. Telehealth platforms and generic alternatives may offer lower prices, so discuss affordability options with your healthcare provider.
